| Investor Type | Firm |
| Stages | Seed |
| Investing | France |
Alkion BioInnovations was created in March 2017 in order to develop disruptive cannabinoid & pharmaceutical API production using large scale plant tissue production. The team works also on a new sugar replacement: a novel plant-based high intensive protein sweetener. The company won many R&D grants: I-lab, I-Nov, Plan de Relance & EIC Phase I; and other prize: La Fabrique Aviva, Netva, Wilco, IPA4SME...

